<DOC>
	<DOCNO>NCT02469480</DOCNO>
	<brief_summary>Iron deficiency high prevalence colorectal cancer patient range ca . 60 % . About 70 % patient suffer iron deficiency anemia ( IDA ) add physical cognitive impediment already strain chemotherapy . Moreover , chronic disease like cancer often result reduce availability iron body . In clinical practice iron substitution usually administer orally . Due low resorption rate , frequent gastric side effect thus poor patient compliance parenteral substitution seem good option term efficacy . In framework randomize multicenter clinical trial ( 'FerInject ' ) comparison efficacy parameter parenteral vs. oral iron substitution conduct order identify best treatment form clinical practice oncology . Furthermore detailed quality life-data ( QoL ) collect treatment arm effect comparison .</brief_summary>
	<brief_title>Intravenous Ferric Carboxymaltose v . Oral Iron Substitution Patients With Metastatic Colorectal Cancer ( CRC ) Iron Deficiency Anemia : Randomized Multicenter Treatment Optimization Study .</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<mesh_term>Glycine</mesh_term>
	<criteria>1 . Metastatic inoperable colorectal carcinoma . No curative therapy available . 2 . Current palliative chemotherapy . Patients conversion therapy must enrol study . 3 . Iron deficiency anemia : hemoglobin ≤ 10.5 g/dl transferrin saturation &lt; 20 % and/or serum ferritin &lt; 20 ng/ml 4 . Male female patient age ≥ 18 year ; maturity 5 . ECOG ≤ 2 6 . Written inform consent 7 . Life expectancy &gt; 6 month 8 . Body weight ≥ 40 kg 1 . Oral intravenous iron substitution within last 4 week 2 . Age &lt; 18 year body weight &lt; 40 kg 3 . Absorption dysfunction due short bowel syndrome gastric resection 4 . Therapy recombinant erythropoietin within last 4 week 5 . Chronic diarrhea 6 . Chronic inflammatory bowel disease 7 . Ferritin &gt; 800 mg/dl baseline 8 . Hypersensitivity contraindication ferric carboxymaltose iron ( II ) glycine sulphate complex 9 . Known vitamin B12 folic acid anemia 10 . Necessary total parenteral nutrition 11 . Participation another interventional study 12 . Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>MCRC</keyword>
	<keyword>iron substitution</keyword>
	<keyword>iron deficiency anemia</keyword>
</DOC>